Being heard on all-oral therapy for resistant tuberculosis

Abstract

Of all the parts of the Sunday service in his little stone church, Pastor Mafukidze (name changed for privacy) liked listening to the choir best of all. Something about all those voices raised together delighted his heart in a way nothing else could. Which is why the high-pitched buzzing sound that developed in his ears only 6 weeks into his treatment for drug-resistant tuberculosis—an early sign of the hearing loss caused by the injectable medication that was part of his therapeutic regimen—filled him with a sense of dread.